Scott Quarrier, MD
Urology · Rochester, NYNPI 1942542782
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,278 of the $39,520 with a category attached, or 74.1%. Cook Incorporated accounts for 75.5% of it on its own, with 8 other manufacturers making up the rest. Among urology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $774.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$30K
- Coloplast$4K
- Cook Medical LLC$3K
- Richard Wolf Medical Instruments Corp.$2K
- KARL Storz Endoscopy-america$786
- Boston Scientific$653
- plus $388 from 3 others
What the payments were for
- Consulting fees$4,38611%
- Speaking & faculty fees$29,27874%
- Travel & lodging$3,78310%
- Food & beverage$2,0745%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 12 | $29,850 |
| Coloplast | 3 | $3,600 |
| Cook Medical LLC | 17 | $2,659 |
| Richard Wolf Medical Instruments Corp. | 5 | $1,584 |
| KARL Storz Endoscopy-america | 1 | $786 |
| Boston Scientific | 6 | $653 |
| Calyxo, Inc. | 2 | $252 |
| Olympus America Inc. | 1 | $90 |
| Ambu Inc. | 4 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LITHO 150$26,358
- Porges Coloplast$3,600
- FIBER DUST$3,023
- Cook$2,325
- NA$786
- LithoVue$387
- S~Curve$263
- CVAC Aspiration System$252
How this compares
$39,520 in reported general payments places this provider in the 90th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tadalafil | 31 | $2,446 |
| Potassium Citrate ErPotassium Citrate | 21 | $1,843 |
| Silodosin | 16 | $1,326 |
| Tamsulosin Hcl | 132 | $1,002 |
| Finasteride | 83 | $744 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 14 | $208 |
| Trospium Chloride | 11 | $154 |
Paid to pharmacies, not to this prescriber.
Other urology in Rochester
- Ahmed GhaziRochester$71K
- Peter WalterJamestown$1.9M
- Christopher PieczonkaSyracuse$797K
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Jeffrey SpencerCheektowaga$430K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.